Tolmar
Develops and manufactures specialty and generic pharmaceutical products.
Company facts
- Founded
- 2006
- Employees
- 1,100
- Headquarters
- United States
- CEO
- Anil D'Souza
- Type
- Private
- Funding
- Corporate Round · 2018
- Subsidiaries
- Tolmar Pharmaceuticals, Tolmar Therapeutics, Tolmar Australia
About
Tolmar is a specialty pharmaceutical company dedicated to developing and delivering specialized, long-acting injectables in the areas of urology, oncology, and endocrinology. Founded in 2007, we've built a reputation for advanced long-acting injectable drug delivery capabilities that set us apart in the pharmaceutical industry. We're not satisfied with the status quo. Our team is motivated to discover, transform, and forge new paths toward advanced patient care and experience. Our vertically integrated approach spans from R&D and polymer development to manufacturing and commercialization, allowing us to maintain quality and control while innovating therapies. This process enabled us to create the first six-month LHRH injectable treatment. Our treatments help patients better manage conditions like central precocious puberty, advanced prostate cancer, and testosterone replacement. We support healthcare providers and patients through advanced therapies, educational resources, patient assistance programs, and community engagement. Our products and services are available in 68 countries worldwide, and we continue to expand our reach through strategic partnerships.